As of 2025-03-19, the Relative Valuation of Inhibrx Inc (INBX) is 3,089.77 USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.94 USD, the upside of Inhibrx Inc based on Relative Valuation is 22064.8%.
The range of the Relative Valuation is 2,213.30 - 4,163.54 USD.
| Range | Selected | |
| Trailing P/E multiples | 21.8x - 36.7x | 29.2x |
| Forward P/E multiples | 19.5x - 31.0x | 25.2x |
| Fair Price | 2,213.30 - 4,163.54 | 3,089.77 |
| Upside | 15777.3% - 29767.5% | 22064.8% |
| Date | P/E |
| 2025-03-03 | 0.12 |
| 2025-02-28 | 0.12 |
| 2025-02-27 | 0.11 |
| 2025-02-26 | 0.11 |
| 2025-02-25 | 0.11 |
| 2025-02-24 | 0.11 |
| 2025-02-21 | 0.11 |
| 2025-02-20 | 0.11 |
| 2025-02-19 | 0.11 |
| 2025-02-18 | 0.12 |
| 2025-02-14 | 0.12 |
| 2025-02-13 | 0.12 |
| 2025-02-12 | 0.11 |
| 2025-02-11 | 0.11 |
| 2025-02-10 | 0.11 |
| 2025-02-07 | 0.11 |
| 2025-02-06 | 0.11 |
| 2025-02-05 | 0.12 |
| 2025-02-04 | 0.11 |
| 2025-02-03 | 0.11 |
| 2025-01-31 | 0.12 |
| 2025-01-30 | 0.12 |
| 2025-01-29 | 0.11 |
| 2025-01-28 | 0.11 |
| 2025-01-27 | 0.11 |
| 2025-01-24 | 0.12 |
| 2025-01-23 | 0.12 |
| 2025-01-22 | 0.12 |
| 2025-01-21 | 0.13 |
| 2025-01-17 | 0.12 |
| 2025-01-16 | 0.12 |
| 2025-01-15 | 0.12 |
| 2025-01-14 | 0.11 |
| 2025-01-13 | 0.12 |
| 2025-01-10 | 0.13 |
| 2025-01-08 | 0.13 |
| 2025-01-07 | 0.14 |
| 2025-01-06 | 0.15 |
| 2025-01-03 | 0.14 |
| 2025-01-02 | 0.13 |
| 2024-12-31 | 0.14 |
| 2024-12-30 | 0.13 |
| 2024-12-27 | 0.13 |
| 2024-12-26 | 0.13 |
| 2024-12-24 | 0.13 |
| 2024-12-23 | 0.13 |
| 2024-12-20 | 0.13 |
| 2024-12-19 | 0.12 |
| 2024-12-18 | 0.12 |
| 2024-12-17 | 0.13 |